Value Assessment Initiative

The PhRMA Foundation has launched the Value Assessment Initiative to help advance high-quality care in the United States, while avoiding low value or inefficient care. The initiative offers generous funding to support research and innovative efforts to assess the value of medicines and health care services, improve patient outcomes and reduce inefficiency.

Kin Fai Au, PhD
University of Iowa
2016 Research Starter Grant in Informatics

Featured Scientist

2017 Foundation grant awardee Hunter Shain, PhD, is part of a cancer research team at UC San Francisco that is systematically tracing how new mutations and changes in gene activity break down cellular protective mechanisms, allowing moles to transform into melanoma and begin to spread.

The new studies also identify new biomarkers that could be used in the clinic to more reliably detect rapidly progressing melanomas that require additional treatment beyond surgical removal.

Announcements

Utilize our site for updates and announcements or follow PhRMA Foundation on twitter @PhRMAFoundation

PhRMA Foundation Surpasses $1.4 Million in Funding for Leaders in Value Assessment

The PhRMA Foundation has announced a new cycle of awards to support transformative strategies that better assess the value of medicines and health care services, improve patient outcomes and reduce inefficiency in health care. More than $1.4 million has been provided to date to establish two national value-assessment Centers of Excellence and support the work of several researchers focused on value-based health care. Learn more about the awards and how to apply for 2019 funding.

PhRMA Alumna Norelle Wildburger: Taking Aim at Alzheimer’s

Norelle Wildburger, PhD, of Washington University in St. Louis is using her PhRMA Foundation funding to better understand the development process of plaque and tangles in Alzheimer’s patients. She and her team have launched a project, working with advanced Alzheimer’s patients who are studied during hospice and whose brains are donated to science following death, that will help shed new light on the timing of Alzheimer’s treatments. A short video video explains and highlights Dr. Wildburger’s work. Watch the video here. Dr. Wildburger was the recipient of a PhRMA Foundation Post-Doctoral Fellowship in Translational Medicine and Therapeutics in 2017.

Learn More About the Foundation in our 2017 Annual Report

Over the last year, the PhRMA Foundation provided more than $3.2 million in funding to dozens of the nation’s leading young researchers, while supporting important new initiatives in areas such as Value Assessment in health care. View a copy of the the annual report here.

Benefactors

The PhRMA Foundation owes its success to the pharmaceutical companies that have provided their generous support over the past 50 years. Click their logos to learn more about them.